Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)

Clinical trial NCT01026415 · COMPLETED

Trial details

NCT number: NCT01026415
Sponsor: Seagen Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinomas Disease, Hodgkin Lymphoma, Large-Cell, Anaplastic Lymphoma, Non-Hodgkin Neoplasms

Start date: 2009-12-01
Primary completion: 2012-05-01
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.